PGI14 DIRECT AND INDIRECT COSTS OF HEPATITIS C VIRUS (HCV)- COMPARISON OF NON-HCV, UNTREATED HCV, AND PEG-RBV TREATED HCV COHORTS
May 1, 2010, 00:00 AM
10.1016/S1098-3015(10)72333-0
https://www.valueinhealthjournal.com/article/S1098-3015(10)72333-0/fulltext
Section Title :
Section Order :
933
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)72333-0&doi=10.1016/S1098-3015(10)72333-0